Comparison of Tolerance of Combination Carboplatin and Paclitaxel Chemotherapy by Age in Women with Ovarian Cancer

By Villella J.A.   Chaudhry T.   Pearl M.L.   Valea F.   DiSilvestro P.A.   Pollack S.   Chalas E.  

Gynecologic Oncology, Vol. 86, Iss. 3, 2002-09 ,pp. : 316-322

Academic Press

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite

Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: Accumulating evidence for synergy, efficacy, and safety

By Pentheroudakis G.   Razis E.   Athanassiadis A.   Pavlidis N.   Fountzilas G.  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 147-160

Humana Press, Inc

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite